Literature DB >> 1821689

Neurofibrillary tangles and beta-amyloid deposits in Alzheimer's disease.

M Goedert1, S S Sisodia, D L Price.   

Abstract

Alzheimer's disease is characterized by the presence of abundant neurofibrillary tangles and beta-amyloid deposits in neocortex, hippocampus and amygdala. The major protein components of tangles and plaques have recently been identified. These findings, briefly reviewed here, will allow researchers to design investigations that will lead to an understanding of the pathogenesis of the disease and to the development of new therapeutic approaches that may result in an effective treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1821689     DOI: 10.1016/0959-4388(91)90067-h

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  30 in total

1.  Mechanisms of cell death in cholinergic basal forebrain neurons in chronic alcoholics.

Authors:  K M Cullen; G M Halliday
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

2.  Advanced Maillard reaction end products are associated with Alzheimer disease pathology.

Authors:  M A Smith; S Taneda; P L Richey; S Miyata; S D Yan; D Stern; L M Sayre; V M Monnier; G Perry
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

3.  Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease.

Authors:  B T Hyman; T E Elvhage; J Reiter
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

4.  Immunological characterization of epitopes on tau of Alzheimer's type and chemically modified tau.

Authors:  G Farías; C González-Billault; R B Maccioni
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

5.  Rapamycin, Autophagy, and Alzheimer's Disease.

Authors:  Zhiyou Cai; Liang-Jun Yan
Journal:  J Biochem Pharmacol Res       Date:  2013-06

6.  Distribution of neuronal growth-promoting factors and cytoskeletal proteins in altered neurites in Alzheimer's disease and non-demented elderly.

Authors:  S S Zhan; W Kamphorst; W E Van Nostrand; P Eikelenboom
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 7.  Neurogenesis and Alzheimer's disease: at the crossroads.

Authors:  Orly Lazarov; Robert A Marr
Journal:  Exp Neurol       Date:  2009-08-19       Impact factor: 5.330

8.  Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau.

Authors:  B Lichtenberg-Kraag; E M Mandelkow; J Biernat; B Steiner; C Schröter; N Gustke; H E Meyer; E Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

Review 9.  Apolipoprotein E and Alzheimer disease.

Authors:  W J Strittmatter; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

10.  Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice.

Authors:  Rhonda L Nelson; Zhihong Guo; Veerendra Madala Halagappa; Michelle Pearson; Audrey J Gray; Yasuji Matsuoka; Martin Brown; Bronwen Martin; Titilola Iyun; Stuart Maudsley; Robert F Clark; Mark P Mattson
Journal:  Exp Neurol       Date:  2007-02-13       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.